Wedbush Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,181
Closed -$614K 1065
2019
Q3
$614K Buy
6,181
+322
+5% +$30.6K 0.06% 368
2019
Q2
$542K Sell
5,859
-5,786
-50% -$549K 0.05% 399
2019
Q1
$1.1M Sell
11,645
-13,770
-54% -$1.2M 0.12% 203
2018
Q4
$1.63M Sell
25,415
-5,869
-19% -$433K 0.21% 115
2018
Q3
$2.8M Sell
31,284
-2,396
-7% -$212K 0.32% 60
2018
Q2
$2.67M Sell
33,680
-14,762
-30% -$1.23M 0.33% 53
2018
Q1
$4.32M Buy
48,442
+6,135
+15% +$589K 0.56% 27
2017
Q4
$4.42M Buy
42,307
+13,995
+49% +$1.58M 0.54% 33
2017
Q3
$4.13M Sell
28,312
-3,165
-10% -$431K 0.54% 34
2017
Q2
$4.09M Buy
31,477
+600
+2% +$73.5K 0.53% 29
2017
Q1
$3.84M Buy
30,877
+2,778
+10% +$332K 0.52% 29
2016
Q4
$3.25M Buy
28,099
+227
+0.8% +$25.3K 0.48% 33
2016
Q3
$2.91M Buy
27,872
+3,323
+14% +$360K 0.43% 43
2016
Q2
$2.42M Buy
24,549
+118
+0.5% +$12.2K 0.4% 51
2016
Q1
$2.44M Buy
24,431
+2,789
+13% +$287K 0.42% 43
2015
Q4
$2.59M Sell
21,642
-1,511
-7% -$175K 0.47% 39
2015
Q3
$2.5M Sell
23,153
-1,388
-6% -$172K 0.5% 33
2015
Q2
$2.84M Buy
24,541
+13
+0.1% +$1.49K 0.52% 23
2015
Q1
$2.83M Buy
24,528
+1,360
+6% +$163K 0.48% 32
2014
Q4
$2.59M Sell
23,168
-2,539
-10% -$268K 0.4% 39
2014
Q3
$2.44M Sell
25,707
-57
-0.2% -$5.14K 0.38% 45
2014
Q2
$2.21M Buy
25,764
+684
+3% +$52K 0.35% 58
2014
Q1
$1.75M Buy
25,080
+3,426
+16% +$271K 0.31% 74
2013
Q4
$1.83M Buy
21,654
+1,668
+8% +$132K 0.43% 57
2013
Q3
$1.54M Buy
19,986
+1,278
+7% +$89.6K 0.41% 65
2013
Q2
$1.09M Buy
+18,708
New +$1.13M 0.3% 90

Other funds holding CELG

Wedbush Securities's CELG Position: Q4 2019 in Review

Wedbush Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,181 shares — an estimated $614K sold.

Wedbush Securities first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.42M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Wedbush Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Wedbush Securities sold 6,181 Celgene Corp shares in Q4 2019, an estimated $614K.
  • Wedbush Securities first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Wedbush Securities's Celgene Corp position peaked at $4.42M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wedbush Securities's 13F filing for Q4 2019, filed 16 Jan 2020.